Nobilis Health Corp. reported unaudited consolidated earnings results for the first quarter ended March 31, 2018. For the quarter, the company reported total revenues of $64,457,000 against $68,302,000 a year ago. The decrease in total revenue was primarily due to the loss of two key physician groups as well as the discontinuation of the company's Lab Testing ancillary service-line. Loss from operations was $2,750,000 against $3,135,000 a year ago. Loss before income taxes and non-controlling interests was $3,845,000 against $3,757,000 a year ago. Net loss was $3,141,000 or $0.05 per basic and fully diluted share against $2,206,000 or $0.03 per basic and fully diluted share a year ago. Net loss attributable to the company was $3,852,000 against $2,398,000 a year ago. Net cash provided by operating activities was $2,665,000 against $16,532,000 a year ago. Purchase of property and equipment was $641,000 against $3,506,000 a year ago. EBITDA was $3,054,000 against LBITDA of $273,000 a year ago. Adjusted EBITDA was $5,086,000 against $2,013,000 a year ago.

For the full year 2018, the company expects revenue in the range of $345.0 million to $355.0 million and adjusted EBITDA in the range of $57.0 million to $62.0 million.